Mexico: Utility Issues In Protection Of Biological Inventions In Mexico

Last Updated: 28 April 1998

Most Read Contributor in Mexico, November 2018
By: Oscar M. Becerril

The concept of utility is relatively new in the Mexican legislation on industrial property, since it was for the first time introduced in the 1991 law and was more clearly defined only in the 1994 law. Prior to the 1991 law, the Mexican patent system was extremely defective and the vast majority of the inventions were not considered as patentable, which therefore restricted the possibility of obtaining patents only to the mechanical inventions and to the methods of obtaining chemical compounds.

The new patent law and particularly the 1994 law, however, by allowing patentability to practically all types of inventions, including those pertaining in the biotechnological field, has practically removed from the analysis the patentability issues and, instead, has now introduced the utility issues which are already being used in connection with the examination of patent applications and that no doubt will have relevance in the future as a reason for the invalidation of granted patents in Mexico.

The definition of invention contained in article 15 of the Mexican patent law, by stating that it must be a human creation for use by man in order to satisfy his concrete needs, undoubtedly calls for compliance with a utility requirement which, in order to be satisfied, requires that a significant use of the invention claimed must exist. On the other hand, the conditions for patentability of inventions stated by article 16 of the Mexican patent law, by establishing that an invention, in order to be patentable, must comply with the requirements of novelty, inventive activity (non obviousness) and industrial application, also involves a definite utility requirement if considered in combination with the condition established by article 12-IV of the Mexican patent law which very clearly states that, in order to have industrial application, an invention must be capable of being used in any branch of the economical activity.

The utility issues incorporated in the new Mexican patent law are already inducing the examiners at IMPI to introduce the concept that an invention, to have utility, must set forth and claim an invention which is operative for at least a purpose set forth in the patent application. However, in order to satisfy the utility requirement, the invention need not be unerringly effective in its operation; all what is required is usefulness in some instances.

Also, the distinction between the operative and the operational is to be noted. The utility requirement is fully satisfied if the claimed invention is operative, that is, if it functions for its intended purpose. There is no requirement that the invention be fully operational, in the sense of the existence of a marketable embodiment, although the existence of commercial success is a definite evidence of operability of the invention.

In connection with biotechnology-related inventions, which often involve a considerable degree of speculation regarding uses of the basic discovery, it is important to consider that the old Mexican Patent Office, in connection with inventions patentable at the time, never considered the existence of inoperative embodiments in a claimed invention to be sufficient reason to invalidate the patent, provided that at least one of the embodiments within the scope of the claimed invention was operative and provided that the remaining embodiments could be rendered operative by one skilled in the art with the addition of elements or selection of conditions of operation which do not constitute a new invention in themselves. As this practice has not been changed up to the present time, it is to be concluded that said practice will be also applicable to biotechnology-related inventions which, therefore, may contain a considerable degree of speculation, provided that said speculation does not go too far so as to constitute an indication of fully inoperative embodiments.

On the other hand, the basic discovery of a biotechnology-related invention may be described and claimed without the need of incorporating all the possible uses to which it is susceptible, because an inventor is not charged with a prophetic understanding of the entire field of usefulness of his invention. The basic principle of patents that an inventor is entitled to every use to which the invention is susceptible, whether or not those uses are known to the inventor at the time of the invention, is fully recognized by the Mexican patent system. Therefore, the owner of a patent whose claims are drawn to structure or basic discovery is entitled to exclude others from using anything embodying said structure or basic discovery, even if the use was neither disclosed nor claimed in his patent. Of course that if one discovers a use for said structure or basic discovery which is new, useful and unobvious, he could be entitled to patent such new use, but the claims drawn to such use would be subservient to those in the earlier patent claiming the structure or basic discovery per se.

Also, an inventor does not need to carry out his invention to the highest degree of perfection to be entitled to obtain a patent. There is no requirement in the Mexican patent law that each and every embodiment within a claim be equally useful for each and every contemplated application, that is, all embodiments within the scope of a claim do not need to be equally effective in order to be entitled to patent protection and, moreover, the Mexican law does not consider the economic or commercial value of an invention to be material to the question of utility.

In specific reference to chemical and biotechnology-related inventions, particularly those that claim products for use in the fields of foods and drugs, the utility requirements may be regarded as somewhat more stringent than those applied to other inventions, in the sense that, in order to comply with the utility requirements, some degree of safety must be shown. In other words, a food product or a drug cannot be considered to have a practical application (usefulness) unless it is safe. Therefore, in order to comply with the utility requirement of the Mexican patent law, a certain minimum level of safety must be demonstrated. However, said level of safety has nothing to do with the standards handled by the Direction for the Control of Foods and Drugs of the Mexican government (equivalent to the Food and Drug Administration of the U. S. A. government). Proof of safety may be required by the IMPI only when adequate reasons can be advanced by then examiner for believing that the drug or the food product is unsafe, and the evidence submitted will be accepted if it establishes a reasonable probability of safety. The documentation required by the Direction for the Control of Foods and Drugs would therefore seem to far exceed that necessary to establish utility under the patent law.

Accordingly, it is quite possible to patent a drug or a food product and yet be unable to market the same as such for failing to meet the standards of safety required by said Direction for the Control of Foods and Drugs.

The showing of utility for biotechnology-related inventions must be effected taking into consideration the provisions of non-patentability for certain inventions, contained in article 16 of the law.

When dealing with essentially biological processes for the production, reproduction and propagation of plants and animals, that is, merely breeding processes, the showing of utility is not enough, unless some chemical or genetic methods can be included to carry out the said breeding and the new transgenic plants or animals are proven to have usefulness.

When a use unknown in the prior art for certain biological or genetic material existing as such in nature is found, although the material per se cannot be patented, the new use per se can be made the subject matter of a valid patent, but in this instance the usefulness of said material must be proven by means of working examples or the like in order to satisfy the utility requirements of the law.

The content of this article is intended only to provide general guidelines related to this particular matter. For your specific circumstances, full specialist advice is recommended.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions